• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在克罗地亚国家乳腺筛查项目中,简化乳腺磁共振成像作为有乳腺癌家族风险史人群乳腺钼靶检查的补充手段

Abbreviated Breast MRI as a Supplement to Mammography in Family Risk History of Breast Cancer within the Croatian National Breast Screening Program.

作者信息

Šupe Parun Andrea, Brkljačić Boris, Ivanac Gordana, Tešić Vanja

机构信息

Croatian Institute for Public Health, 10 000 Zagreb, Croatia.

Breast Unit, Department of Diagnostic and Interventional Radiology, University Hospital Dubrava, 10 000 Zagreb, Croatia.

出版信息

Biomedicines. 2024 Oct 16;12(10):2357. doi: 10.3390/biomedicines12102357.

DOI:10.3390/biomedicines12102357
PMID:39457669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11505497/
Abstract

OBJECTIVE

To evaluate the diagnostic performance of abbreviated breast MRI compared with mammography in women with a family history of breast cancer included in the Croatian National Breast Screening Program.

METHODS

178 women with a family history of breast cancer aged 50 to 69 underwent abbreviated breast MRI and mammography. Radiological findings for each method were categorized according to the BI-RADS classification. The gold standard for assessing the diagnostic accuracy of breast MRI and mammography, in terms of suspicious BI-RADS 4 and BI-RADS 5 findings, was the histopathological diagnosis. Performance measures, including cancer detection rates, specificity, sensitivity, and positive and negative predictive values, were calculated for both imaging methods.

RESULTS

Twelve new cases of breast cancer were detected, with seven (58.3%) identified only by abbreviated breast MRI, four (33.3%) detected by both mammography and breast MRI, and one (8.3%) diagnosed only by mammography. Diagnostic accuracy parameters for abbreviated breast MRI were 91.67% sensitivity, 94.58% specificity, 55.0% positive predictive value (PPV), and 99.37% negative predictive value (NPV), while for mammography, the corresponding values were 41.67%, 96.39%, 45.46%, and 95.81%, respectively.

CONCLUSIONS

Abbreviated breast MRI is a useful supplement to screening mammography in women with a family history of breast cancer. Considering the results of the conducted research, it is recommended to assess whether women with a family history of breast cancer have an increased risk and subsequently provide annual abbreviated breast MRI in addition to mammography for early detection of breast cancer.

摘要

目的

评估在克罗地亚国家乳腺癌筛查项目中,与乳腺钼靶相比,简化乳腺磁共振成像(MRI)对有乳腺癌家族史女性的诊断性能。

方法

178名年龄在50至69岁、有乳腺癌家族史的女性接受了简化乳腺MRI和乳腺钼靶检查。每种检查方法的影像学结果根据乳腺影像报告和数据系统(BI-RADS)分类进行归类。评估乳腺MRI和乳腺钼靶诊断准确性的金标准,针对可疑的BI-RADS 4类和BI-RADS 5类结果,是组织病理学诊断。计算两种成像方法的性能指标,包括癌症检出率、特异性、敏感性以及阳性和阴性预测值。

结果

共检测出12例新发乳腺癌病例,其中7例(58.3%)仅通过简化乳腺MRI检出,4例(33.3%)通过乳腺钼靶和乳腺MRI均检测出,1例(8.3%)仅通过乳腺钼靶诊断出。简化乳腺MRI的诊断准确性参数为敏感性91.67%、特异性94.58%、阳性预测值(PPV)55.0%和阴性预测值(NPV)99.37%,而乳腺钼靶的相应值分别为41.67%、96.39%、45.46%和95.81%。

结论

简化乳腺MRI是对有乳腺癌家族史女性进行乳腺钼靶筛查的有用补充。考虑到所开展研究的结果,建议评估有乳腺癌家族史的女性是否有更高风险,随后除乳腺钼靶外,每年提供简化乳腺MRI以早期发现乳腺癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0468/11505497/a335545525dc/biomedicines-12-02357-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0468/11505497/5fb3cdfe4e7f/biomedicines-12-02357-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0468/11505497/a335545525dc/biomedicines-12-02357-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0468/11505497/5fb3cdfe4e7f/biomedicines-12-02357-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0468/11505497/a335545525dc/biomedicines-12-02357-g002.jpg

相似文献

1
Abbreviated Breast MRI as a Supplement to Mammography in Family Risk History of Breast Cancer within the Croatian National Breast Screening Program.在克罗地亚国家乳腺筛查项目中,简化乳腺磁共振成像作为有乳腺癌家族风险史人群乳腺钼靶检查的补充手段
Biomedicines. 2024 Oct 16;12(10):2357. doi: 10.3390/biomedicines12102357.
2
3
Added value of abbreviated breast magnetic resonance imaging for assessing suspicious microcalcification on screening mammography-a prospective study.乳腺磁共振成像在评估筛查性钼靶微钙化中的附加价值:一项前瞻性研究。
Eur Radiol. 2022 Feb;32(2):815-821. doi: 10.1007/s00330-021-08196-y. Epub 2021 Aug 3.
4
Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.BI-RADS 3-5级微钙化患者的对比增强磁共振成像
Radiol Med. 2007 Mar;112(2):272-86. doi: 10.1007/s11547-007-0141-9. Epub 2007 Mar 19.
5
Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.在接受筛查的致密型乳腺女性中,比较用于乳腺癌检测的简化乳腺 MRI 与数字乳腺断层合成术。
JAMA. 2020 Feb 25;323(8):746-756. doi: 10.1001/jama.2020.0572.
6
Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.对比增强光谱乳腺摄影在具有中等乳腺癌风险和乳腺致密的女性中的应用。
AJR Am J Roentgenol. 2018 Nov;211(5):W267-W274. doi: 10.2214/AJR.17.19355. Epub 2018 Sep 21.
7
Unveiling the potential of breast MRI: a game changer for BI-RADS 4A microcalcifications.揭示乳腺 MRI 的潜力:BI-RADS 4A 微钙化的变革者。
Breast Cancer Res Treat. 2024 Jul;206(2):425-435. doi: 10.1007/s10549-024-07320-y. Epub 2024 Apr 26.
8
[Analysis of the results of mammography screening in Dubrovnik-Neretva County in the 2006-2009 period].[2006 - 2009年期间杜布罗夫尼克 - 内雷特瓦县乳腺钼靶筛查结果分析]
Acta Med Croatica. 2010 Dec;64(5):453-9.
9
An Abbreviated Protocol for High-risk Screening Breast Magnetic Resonance Imaging: Impact on Performance Metrics and BI-RADS Assessment.一种用于高危筛查的乳腺磁共振成像简化方案:对性能指标和BI-RADS评估的影响
Acad Radiol. 2017 Sep;24(9):1132-1138. doi: 10.1016/j.acra.2017.03.014. Epub 2017 May 11.
10
Comparison of Abbreviated MRI with Mammography and Ultrasound in Women with a Personal History of Breast Cancer.有乳腺癌病史的女性的 MRI 简化检查与乳腺 X 线摄影及超声检查的比较。
Acad Radiol. 2022 Jan;29 Suppl 1:S19-S25. doi: 10.1016/j.acra.2021.05.022. Epub 2021 Jun 24.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
The paradox of MRI for breast cancer screening: high-risk and dense breasts-available evidence and current practice.乳腺癌筛查中MRI的悖论:高危和致密型乳腺——现有证据及当前实践
Insights Imaging. 2024 Mar 27;15(1):96. doi: 10.1186/s13244-024-01653-4.
3
Abbreviated Breast MRI Utilization: A Survey of the Society of Breast Imaging.
乳腺磁共振成像的应用现状:乳腺影像学协会的调查。
J Breast Imaging. 2022 Oct 10;4(5):506-512. doi: 10.1093/jbi/wbac048.
4
Economic evaluation of breast MRI in screening - a systematic review and basic approach to cost-effectiveness analyses.乳腺磁共振成像筛查的经济学评估——系统评价及成本效益分析的基本方法
Front Oncol. 2023 Dec 7;13:1292268. doi: 10.3389/fonc.2023.1292268. eCollection 2023.
5
Comparative Performance of Contrast-enhanced Mammography, Abbreviated Breast MRI, and Standard Breast MRI for Breast Cancer Screening.对比增强钼靶 X 线摄影、简化式乳腺 MRI 与标准乳腺 MRI 筛查乳腺癌的对比效能评估。
Radiology. 2023 Aug;308(2):e230576. doi: 10.1148/radiol.230576.
6
Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR.美国放射学会更新的高风险女性乳腺癌筛查推荐建议。
J Am Coll Radiol. 2023 Sep;20(9):902-914. doi: 10.1016/j.jacr.2023.04.002. Epub 2023 May 5.
7
Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer-How Low-Cost Must MRI Be?数字乳腺断层合成术与简化乳腺磁共振成像用于筛查乳腺癌中度风险女性的成本效益——磁共振成像的成本必须多低?
Cancers (Basel). 2021 Mar 12;13(6):1241. doi: 10.3390/cancers13061241.
8
A meta-analysis comparing the diagnostic performance of abbreviated MRI and a full diagnostic protocol in breast cancer.比较乳腺癌缩短 MRI 和完整诊断方案的诊断性能的荟萃分析。
Clin Radiol. 2021 Feb;76(2):154.e23-154.e32. doi: 10.1016/j.crad.2020.08.036. Epub 2020 Oct 5.
9
Worldwide Review and Meta-Analysis of Cohort Studies Measuring the Effect of Mammography Screening Programmes on Incidence-Based Breast Cancer Mortality.测量乳腺钼靶筛查计划对基于发病率的乳腺癌死亡率影响的队列研究的全球综述与荟萃分析
Cancers (Basel). 2020 Apr 15;12(4):976. doi: 10.3390/cancers12040976.
10
Use of detailed family history data to improve risk prediction,with application to breast cancer screening.利用详细的家族史数据提高风险预测能力,并应用于乳腺癌筛查。
PLoS One. 2019 Dec 17;14(12):e0226407. doi: 10.1371/journal.pone.0226407. eCollection 2019.